ABCG2 and breast carcinoma: These results are in agreement with those obtained by Mukherjee et al. [91] and Amawi et al. [92], who described that PX treatment increases the activation and expression of ABCG2 in different breast cancer cell lines and that this factor could mediate the resistance to treatment [5].